Literature DB >> 23715934

Malignant melanoma: epidemiologic aspects, diagnostic and therapeutic approach.

Michael Tronnier1, Kristina Semkova, Uwe Wollina, Georgi Tchernev.   

Abstract

In faired skinned population the incidence of melanoma is rapidly increasing. Beside environmental factors (UV-exposure) certainly other reasons for the observed "melanoma epidemic" have to be discussed. For diagnostic procedure classical histopathology is accompanied by immunohistochemistry and more recently molecular techniques. For therapy new modalities are available which-after many years of frustrating search for new drugs-are now able to prolong both disease/progression free and overall survival.

Entities:  

Mesh:

Year:  2013        PMID: 23715934     DOI: 10.1007/s10354-013-0207-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  33 in total

1.  Digital dermoscopy in clinical practise: a three-centre analysis.

Authors:  Uwe Wollina; Marco Burroni; Rocco Torricelli; Stefano Gilardi; Giordana Dell'Eva; Cathrine Helm; Wolfgang Bardey
Journal:  Skin Res Technol       Date:  2007-05       Impact factor: 2.365

Review 2.  The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.

Authors:  Zahra Hanaizi; Barbara van Zwieten-Boot; Gonzalo Calvo; Arantxa Sancho Lopez; Maaike van Dartel; Jorge Camarero; Eric Abadie; Francesco Pignatti
Journal:  Eur J Cancer       Date:  2011-10-24       Impact factor: 9.162

Review 3.  Incisional biopsy and melanoma prognosis: Facts and controversies.

Authors:  Annette Pflugfelder; Benjamin Weide; Thomas Kurt Eigentler; Andrea Forschner; Ulrike Leiter; Laura Held; Friedegund Meier; Claus Garbe
Journal:  Clin Dermatol       Date:  2010 May-Jun       Impact factor: 3.541

4.  Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.

Authors:  Lorenzo Cerroni; Raymond Barnhill; David Elder; Geoffrey Gottlieb; Peter Heenan; Heinz Kutzner; Philip E LeBoit; Martin Mihm; Juan Rosai; Helmut Kerl
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

5.  Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Authors:  Jeffrey A Sosman; Kevin B Kim; Lynn Schuchter; Rene Gonzalez; Anna C Pavlick; Jeffrey S Weber; Grant A McArthur; Thomas E Hutson; Stergios J Moschos; Keith T Flaherty; Peter Hersey; Richard Kefford; Donald Lawrence; Igor Puzanov; Karl D Lewis; Ravi K Amaravadi; Bartosz Chmielowski; H Jeffrey Lawrence; Yu Shyr; Fei Ye; Jiang Li; Keith B Nolop; Richard J Lee; Andrew K Joe; Antoni Ribas
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

6.  A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up.

Authors:  Josefine Beger; Gesina Hansel; Claudia Krönert; Martin Fuchs; Carmen Tanner; Jaqueline Schönlebe; Carmen Werner; Andreas Nowak; Gunter Haroske; Helmut Witzigmann; Uwe Wollina
Journal:  Int J Dermatol       Date:  2013-02       Impact factor: 2.736

7.  Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.

Authors:  A M Powell; A M Robson; R Russell-Jones; R J Barlow
Journal:  Br J Dermatol       Date:  2009-02-16       Impact factor: 9.302

8.  Increasing burden of melanoma in the United States.

Authors:  Eleni Linos; Susan M Swetter; Myles G Cockburn; Graham A Colditz; Christina A Clarke
Journal:  J Invest Dermatol       Date:  2009-01-08       Impact factor: 8.551

9.  Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.

Authors:  Alice Hervieu; Cédric Rébé; Frédérique Végran; Fanny Chalmin; Mélanie Bruchard; Pierre Vabres; Lionel Apetoh; François Ghiringhelli; Grégoire Mignot
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

10.  A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

Authors:  Evan M Hersh; Steven J O'Day; John Powderly; Khuda D Khan; Anna C Pavlick; Lee D Cranmer; Wolfram E Samlowski; Geoffrey M Nichol; Michael J Yellin; Jeffrey S Weber
Journal:  Invest New Drugs       Date:  2010-01-16       Impact factor: 3.651

View more
  3 in total

Review 1.  The value of metastasectomy in stage IV cutaneous melanoma.

Authors:  Uwe Wollina; Piotr Brzezinski
Journal:  Wien Med Wochenschr       Date:  2018-03-06

2.  Subungual Nail Pigmentation and Malalignment of the Great Toe Nail in a Cancer Patient - A Diagnostic Challenge.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Open Access Maced J Med Sci       Date:  2017-07-20

Review 3.  Treating advanced melanoma: current insights and opportunities.

Authors:  Michael Tronnier; Christina Mitteldorf
Journal:  Cancer Manag Res       Date:  2014-09-10       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.